Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.36 |
| ▸ | BRD4 | O60885 | 1/20 | 0.34 |
| ▸ | BRD2 | P25440 | 1/20 | 0.34 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.34 |
| ▸ | TRIM24 | O15164 | 2/20 | 0.33 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.33 |
| ▸ | TOP2A | P11388 | 2/20 | 0.32 |
| ▸ | TOP2B | Q02880 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.31 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.31 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.31 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3741338 | 0.98 | ALDH1A1 (0.38) | ALDH1A1L3MBTL1GAATHRBPIK3CD | |
| Bromide SCHEMBL3734670 | 0.98 | ALDH1A1 (0.38) | ALDH1A1L3MBTL1GAATHRBPIK3CD | |
| SCHEMBL11776413 | 0.93 | ALDH1A1 (0.38) | ALDH1A1L3MBTL1GAATHRBPIK3CD | |
| SCHEMBL4790280 | 0.92 | CHRNA7 (0.38) | ALDH1A1L3MBTL1GAATHRBPIK3CD | |
| SCHEMBL11670185 | 0.86 | — | — | |
| SCHEMBL4793731 | 0.84 | CHRM2 (0.40) | ALDH1A1L3MBTL1GAATHRBPIK3CD | |
| SCHEMBL3738896 | 0.84 | HRH3 (0.33) | ALDH1A1L3MBTL1GAATHRBCHRNA7 | |
| SCHEMBL12205477 | 0.82 | CHRNA7 (0.43) | ALDH1A1L3MBTL1GAATHRBPIK3CD | |
| Hydrochloric Acid SCHEMBL3738834 | 0.79 | GRIA1 (0.39) | PIK3CDBRD4BRD2TOP2ATOP2B | |
| Bromide SCHEMBL3739300 | 0.79 | GRIA1 (0.39) | PIK3CDBRD4BRD2TOP2ATOP2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114516925-A | Photopolymerization initiation system based on nitrogen-containing heterocyclic ketone compound and photopolymerization method thereof | 海南师范大学 | 2022-05-20 | — | — | CN | claimed |
| US-20250206884-A1 | ULTRAVIOLET RADIATION-CURABLE POLYSILOXANE COMPOSITION, AND DAMPING MATERIAL | TAICA CORPORATION (JP) | 2025-06-26 | — | — | US | disclosed |
| CN-118974144-A | Ultraviolet-curable polysiloxane composition and damping material | 株式会社泰已科 | 2024-11-15 | — | — | CN | disclosed |
| US-12030869-B2 | 5-membered heteroaryl carboxamide compounds for treatment of HBV | ASSEMBLY BIOSCIENCES, INC. (US) | 2024-07-09 | — | — | US | disclosed |
| US-11873291-B2 | Quinoline cGAS antagonist compounds | IMMUNESENSOR THERAPEUTICS, INC. (US) | 2024-01-16 | — | — | US | disclosed |
| US-11834436-B2 | Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof | ENANTA PHARMACEUTICALS, INC. (US) | 2023-12-05 | — | — | US | disclosed |
| WO-2023189433-A1 | ULTRAVIOLET RADIATION-CURABLE POLYSILOXANE COMPOSITION, AND DAMPING MATERIAL | 株式会社タイカ | 2023-10-05 | — | — | WO | disclosed |
| CN-114516925-B | Photopolymerization initiation system based on nitrogen-containing heterocyclic ketone compound and photopolymerization method thereof | 海南师范大学 | 2023-07-14 | — | — | CN | disclosed |
| EP-3495341-B1 | PREPARATION PROCESS OF PERFLUOROALKYL COMPOUND WITH MONOHYDROPERFLUOROALKANE AS STARTING MATERIAL | KANTO DENKA KOGYO KK (JP) | 2022-11-02 | — | — | EP | disclosed |
| CN-114516925-A | Photopolymerization initiation system based on nitrogen-containing heterocyclic ketone compound and photopolymerization method thereof | 海南师范大学 | 2022-05-20 | — | — | CN | disclosed |
| WO-2007137676-A2 | LIGHTENING AND/OR COLOURING AGENT COMPRISING CYCLIC UREA DERIVATIVES | HENKEL AG & CO. KGAA (DE) | 2007-12-06 | — | — | WO | disclosed |
| EP-1862198-A2 | Brightening and/or dyeing agent with urea derivatives | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-12-05 | — | — | EP | disclosed |
| US-20070259924-A1 | FACTOR XA INHIBITORS | MILLENNIUM PHARMACEUTICALS, INC. | 2007-11-08 | — | — | US | disclosed |
| WO-2007118617-A1 | BLEACHING AND/OR COLOURING AGENTS CONTAINING PIPERIDONES | HENKEL AG & CO. KGAA (DE) | 2007-10-25 | — | — | WO | disclosed |
| US-7262186-B2 | Substituted pyrazolo[3,4-d] pyrimidinones as a mitotic kinesin inhibitor | MERCK & CO., INC. (US) | 2007-08-28 | — | — | US | disclosed |
| US-7262187-B2 | Substituted oxazolo- and thizaolopyrimidinones as a mitotic kinesin inhibitor | MERCK & CO., INC. (US) | 2007-08-28 | — | — | US | disclosed |
| US-7244723-B2 | Substituted furopyrimidinones as a mitotic kinesin inhibitors | MERCK & CO., INC. (US) | 2007-07-17 | — | — | US | disclosed |
| US-7192949-B2 | Substituted bicyclic pyrimidinones as a mitotic kinesin KSP inhibitors | MERCK & CO., INC. (US) | 2007-03-20 | — | — | US | disclosed |
| US-4680302-A | ANTIDEPRESSANTS | LABORATOIRE L. LAFON (FR) | 1987-07-14 | — | — | US | disclosed |
| EP-0192522-A1 | 1-ethyl- 3-hydroxy-3-phenylpiperidine, process for its preparation and its therapeutical use | LABORATOIRE L. LAFON Société anonyme dite: (FR) | 1986-08-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11873291-B2 | Quinoline cGAS antagonist compounds | CGAS, GLS2, GLS | ALDH1A1 4236/4885L3MBTL1 4285/4885GAA 27/4885 |
| US-20070259924-A1 | FACTOR XA INHIBITORS | TFPI, F12, F11 | ALDH1A1 911/4885L3MBTL1 3799/4885GAA 324/4885 |
| US-11834436-B2 | Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof | AIFM1, BAD, IRAK1 | ALDH1A1 1233/4885L3MBTL1 3138/4885GAA 1661/4885 |
| US-12030869-B2 | 5-membered heteroaryl carboxamide compounds for treatment of HBV | HCCS, HAVCR2, MAVS | ALDH1A1 4534/4885L3MBTL1 2951/4885GAA 2553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.